Employee Wellbeing | Weighing up Weight-Loss Benefits Provision

Why It Matters

Integrating GLP‑1 drug coverage could lower absenteeism, boost productivity, and position employers as proactive health partners, reshaping the employee‑benefits landscape.

Key Takeaways

• 26% employees have used weight‑loss drugs.
• 41% demand weight‑loss medication in benefits.
• GLP‑1 users cut average sick days by 5.2.
• Obesity adds up to six extra sick days annually.
• Large employers likely to add GLP‑1 benefits soon.

Pulse Analysis

Obesity remains a pressing public‑health challenge in the UK, with nearly one‑third of adults classified as clinically obese and another 36% overweight. The surge of GLP‑1 medications—most notably Ozempic and Mounjaro—has shifted the conversation from diet plans to clinically proven pharmacotherapy, promising substantial weight loss and associated health benefits. As these drugs gain mainstream acceptance, employees are increasingly viewing weight‑loss support as a legitimate workplace need, prompting a reevaluation of traditional wellness programs.

Recent data from Howden Employee Benefits reveals that 26% of workers have already used GLP‑1 drugs, and 41% now consider them a necessary addition to benefits packages. Employers stand to gain: Yazen’s pilot across 1,351 European patients showed participants on GLP‑1 therapy missed 5.2 fewer sick days per year, with nearly half reporting higher energy levels at work. For large employers—especially the NHS, where obesity‑related absenteeism can be three times higher than the broader workforce—offering such support could translate into measurable cost savings and enhanced employee morale.

Looking ahead, industry analysts anticipate a rapid market shift, with weight‑loss benefits becoming as commonplace as fertility support within five years. While the promise is clear, companies must navigate cost structures, regulatory considerations, and potential equity concerns. Strategic steps include piloting GLP‑1 coverage, partnering with specialist providers like Yazen or Juniper, and integrating coaching services to maximize outcomes. Early adopters will likely set the benchmark, creating a domino effect that reshapes employee health benefits across the UK.